China (Mainland)
Simvastatin CAS NO.79902-63-9
- FOB Price: USD: 100.00-100.00 /Metric Ton Get Latest Price
- Min.Order: 1 Gram
- Payment Terms: T/T,
- Available Specifications:
99%(5-10)Metric Ton
- Product Details
Keywords
- Simvastatin
- Simvastatin,chemical
- 79902-63-9,C25H38O5
Quick Details
- ProName: Simvastatin
- CasNo: 79902-63-9
- Molecular Formula: C25H38O5
- Appearance: powder
- Application: Anabolic steroid.
- DeliveryTime: within 1-2days
- PackAge: bag
- Port: China
- ProductionCapacity: 10 Metric Ton/Month
- Purity: 99
- Storage: store in a cool dry place
- Transportation: Express,air
- LimitNum: 1 Gram
Superiority
| Product Name: | Simvastatin |
| Synonyms: | (1s-(1-alpha,3-dro-4-hydroxy-6-oxo-2h-pyran-2-yl)ethyl)-1-naphthalenyleste;7-beta,8-beta(2s*,4s*),8a-beta))-alph;butanoicacid,2,2-dimethyl-,1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahy;l644128-000u;mk-0733;LIPONORM;(1S,3R,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-3,7-DIMETHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HYDROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENYLY-2,2-DIMETHYL BUTANOATE;2,2-DIMETHYL-BUTYRIC ACID (1S,3R,7S,8S,8AR)-8-[2-((2R,4R)-4-HYDROXY-6-OXO-TETRAHYDRO-PYRAN-2-YL)-ETHYL]-3,7-DIMETHYL-1,2,3,7,8,8A-HEXAHYDRO-NAPHTHALEN-1-YL ESTER |
| CAS: | 79902-63-9 |
| MF: | C25H38O5 |
| MW: | 418.57 |
| EINECS: | 404-520-2 |
| Product Categories: | Antibiotics;APIs;Simvastatin;Inhibitors;Intermediates & Fine Chemicals;Pharmaceuticals;API's;HMG-CoA reductase;Chiral Reagents;Heterocycles;MOBIC;API |
| Mol File: | 79902-63-9.mol |
Details
| Simvastatin Usage And Synthesis |
| Lipid-lowering drugs |
Simvastatin is a cholesterol-lowering drug of statin, is a synthetic derivative of Aspergillus terreus fermentation product, is used to control blood cholesterol levels and prevent cardiovascular disease. Simvastatin belongs to methyl hydroxyl coenzyme A (HMG-COA) reductase inhibitors, inhibits synthesis of endogenous cholesterol, and is the lipid regulator. Has a role in reducing cholesterol (TC) content of serum, liver and aorta in hyperlipidemia rabbits reducing levels of very low density lipoprotein cholesterol (VLDL-C) and low-density lipoprotein cholesterol (LDL-C). |
| Indications |
1. Hyperlipidemia: (1) For patients with primary hypercholesterolemia, heterozygous familial hypercholesterolemia or mixed hypercholesterolemia, when diet and other non-drug treatment is not ideal, Simvastatin can be used to reduce the increased total cholesterol, LDL cholesterol, apolipoprotein B and triglycerides. And Simvastatin increases high-density lipoprotein cholesterol, thereby reducing the LDL / HDL and total cholesterol / HDL ratio. (2) For patients with homozygous familial hypercholesterolemia, when diet and non-diet is not ideal, Simvastatin can be used to reduce elevated total cholesterol, LDL cholesterol and apolipoprotein B. 2. Coronary heart disease: Coronary heart disease, Simvastatin can be used to: (1) reduce the risk of death. (2) reduce risk of coronary heart disease death and nonfatal myocardial infarction. (3) reduce risk of stroke and transient ischemic. (4) reduce risk of myocardial revascularization (coronary artery bypass grafting and percutaneous coronary balloon angioplasty). (5) delay the progression of atherosclerosis in the arteries, including the all-new lesions and the occurrence of full clogging. The above information is edited by the chemicalbook of Liu Yujie. |
| Chemical properties | White crystalline powder, odorless. Soluble in ethanol, acetone or acetonitrile, difficult soluble in ether, practically insoluble in water. Melting point is 135 ~ 138 ℃. |
| Application |
1. HMG-CoA reductase inhibitors, can reduce the concentration of serum total cholesterol level, inhibit synthesis of cholesterol. For treatment of primary hypercholesterolemia with cholesterol levels greater than 7.8mmol / L which is invalid or not tolerated in other treatments. 2. Has role in reducing cholesterol, low-density lipoprotein cholesterol and very low density lipoprotein cholesterol. |